Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

This study has been completed.

First Received on August 3, 2005. Last Updated on December 8, 2011 History of Changes

Sponsor:	Alberta Health Services
Information provided by (Responsible Party):	Alberta Health Services
ClinicalTrials.gov Identifier:	NCT00126815

Purpose

Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.

Condition
Prostate Cancer

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Retrospective
Official Title:	Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Resource links provided by NLM:

MedlinePlus related topics: Cancer Prostate Cancer

U.S. FDA Resources

Further study details as provided by Alberta Health Services:

Enrollment:	1000
Study Start Date:	February 2004
Study Completion Date:	April 2008
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)

Detailed Description:

Clinical data (prostate-specific antigen [PSA] response after radiotherapy) are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.

Eligibility

Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

primary care clinic

Criteria

Inclusion Criteria:

Prostate cancer treated with radiotherapy +/- hormones

Exclusion Criteria:

Prostatectomy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00126815

Locations

Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2

Sponsors and Collaborators

Alberta Health Services

Investigators

Principal Investigator:

Matthew Parliament, MD

Alberta Health Services

More Information

No publications provided

Responsible Party:	Alberta Health Services
ClinicalTrials.gov Identifier:	NCT00126815 History of Changes
Other Study ID Numbers:	NA-15-0002
Study First Received:	August 3, 2005
Last Updated:	December 8, 2011
Health Authority:	Canada: Health Canada

Keywords provided by Alberta Health Services:

prostate cancer
prostate specific antigen
radiotherapy
mathematical modeling

Additional relevant MeSH terms:

Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site

Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on February 12, 2012